No menu items!

Prescription Recalls

Xarelto Lawsuits Continue To Rise

Xarelto Lawsuits continue to be on the rise for the United States. Xarelto is an anticoagulant medication used to reduce the risk of blood clots and strokes. The drug has been linked to an...

Doctors Neglecting Weapon Against Fighting Opioid Deaths

Recently Bloomberg published an article on Doctors Neglecting Weapon Against Fighting Opioid Deaths. The U.S. is in the midst of an opioid crisis. Deaths from prescription painkiller overdoses have quadrupled since 1999. To combat the...

Many drug-makers filing incomplete side effect reports to FDA, analysis concludes

STAT (2/23, Silverman) reports that a new analysis published in Pharmacoepidemiology and Drug Safety concludes that drug-makers “generally fail to include key data that the FDA might use to assess future warnings” in their...

Pfizer facing wave of lawsuits over anti-cholesterol treatment

Pharmaceutical giant Pfizer is facing a mounting wave of lawsuits by women who allege that the company knew about possible serious side effects of its blockbuster anti-cholesterol drug Lipitor but never properly warned the...

Monitoring, Dose Adjustment for Pradaxa

Blood level monitoring and dose adjustment for dabigatran (Pradaxa) could reduce major bleeding risk by as much as 20% compared with unadjusted use, according to company analyses allegedly hidden from physicians and regulators. An investigation...

Japan drug maker Takeda to fight $6 billion damages awarded by U.S. jury

Takeda Pharmaceutical Co Ltd said it would contest $6 billion in punitive damages imposed by a jury in the United States in a case that accused Japan's largest drug maker of concealing cancer risks...

Testosterone Product Injuries

The U.S. Food and Drug Administration (FDA) is advising the public that it is evaluating studies showing that prescription testosterone products might cause stroke, heart attacks, and death in men who use them. What Are...

Lipitor Diabetes Lawsuits

In early 2012, analysis of clinical trial results prompted the U.S. Food and Drug Administration (FDA) to change the labels of the cholesterol-reducing drug Lipitor to state that it increases a user’s risk of...

Recent posts

Popular categories